ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.07
0.46%
US Tech 100
17,244.80
1.57%
S&P 500
5,099.96
1.02%
US Dollar vs CAD
1.36805
0.00%
Bitcoin
63,483.70
0.11%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Synlogic Inc (SYBX)

  7. Synlogic Inc (SYBX) News

SYBX Synlogic Inc

1.87
0.01 (0.54%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Synlogic Inc SYBX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.01 0.54% 1.87 15:00:09
Open Price Low Price High Price Close Price Previous Close
1.87 1.84 1.88 1.87 1.86
more quote information »

Recent News

Date Time Source Heading
3/19/202406:00GLOBESynlogic Reports Fourth Quarter and Full Year 2023 Financial..
2/22/202415:37EDGAR2Form 8-K - Current report
2/20/202416:05EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
2/20/202415:06EDGAR2Form 8-K - Current report
2/20/202411:15GLOBESynlogic Adopts Limited Duration Stockholders Rights Plan
2/16/202415:54EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/16/202415:44EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2/14/202414:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/12/202415:00EDGAR2Form 8-K - Current report
2/08/202415:15GLOBESynlogic Announces Decision to Discontinue Synpheny-3 Study..
2/02/202411:00GLOBESynlogic Announces Publication of Preclinical and Clinical..
1/04/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202406:00GLOBESynlogic Provides Corporate Update and Outlook for 2024
12/29/202315:00EDGAR2Form 8-K - Current report
12/27/202306:00GLOBESynlogic Announces Contract with the Air Force Research Lab
12/07/202306:00GLOBESynlogic Announces Abstract Accepted for Poster Presentation..
11/17/202315:00EDGAR2Form 8-K - Current report
11/14/202318:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202318:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202318:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202306:00GLOBESynlogic Reports Third Quarter 2023 Financial Results and..
11/09/202305:44EDGAR2Form 8-K - Current report
11/09/202305:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202306:00GLOBESynlogic Achieves Research Milestone and Earns $2.5 Million..
11/07/202305:45EDGAR2Form 8-K - Current report
10/13/202315:17EDGAR2Form SC 13D/A - General statement of acquisition of..
10/03/202315:15GLOBESynlogic Announces Closing of $21.0 Million Underwritten..
10/02/202316:05EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
9/29/202307:53EDGAR2Form 8-K - Current report
9/29/202306:00GLOBESynlogic Announces Pricing of $21.0 Million Underwritten..
9/28/202320:43EDGAR2Form S-1MEF - Registration adding securities to prior Form..
9/28/202315:15EDGAR2Form 8-K - Current report
9/28/202310:15GLOBESynlogic Announces Publication of Synpheny-1 Phase 2 Study..
9/28/202307:39EDGAR2Form S-1/A - General form for registration of securities..
9/27/202311:30GLOBESynlogic Announces Reverse Stock Split
9/26/202320:41EDGAR2Form S-1/A - General form for registration of securities..
9/22/202315:15EDGAR2Form 8-K - Current report
9/21/202306:00GLOBESynlogic to Participate in Chardan’s Genetic Medicines..
9/19/202310:00GLOBESynlogic Announces CEO Aoife Brennan Named to PharmaVoice..
9/08/202315:06EDGAR2Form S-1 - General form for registration of securities under..
9/01/202307:00EDGAR2Form DEF 14A - Other definitive proxy statements
8/21/202316:15EDGAR2Form PRE 14A - Other preliminary proxy statements
8/16/202315:05EDGAR2Form 8-K - Current report
8/10/202306:00GLOBESynlogic Reports Second Quarter 2023 Financial Results and..
8/10/202305:35EDGAR2Form 8-K - Current report
8/10/202305:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/11/202306:00GLOBESynlogic Granted Fast Track Designation from FDA for..
6/28/202306:00GLOBESynlogic Announces International Nonproprietary Name..
6/27/202306:00GLOBESynlogic Announces Participation in SVB Securities..
6/08/202305:45GLOBESynlogic Reminds Stockholders of 2023 Annual General Meeting..

Your Recent History

NASDAQ
SYBX
Synlogic
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved